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ABSTRACT
Boswellia serrata (Burseraceae) is one of the oldest and most explored herbs in Ayurveda. In Unani system of medicine, oleo-gum resin of B. serrata 
named Kundur has been a key component of modern quality perfumes. The gum is used as a remedy for the treatment of illness especially skin diseases 
and rheumatism in Indian system of medicine (Siddha, Ayurvedic, and Unani) for the preceding centuries. Salai guggul is one of the accepted drugs 
for various complaints such as dyspepsia, dysentery, lung diseases, urinary disorder, hemorrhoids, and corneal ulcer in Unani system of medicine 
for the past few decades. The present article is aimed to provide an overview on various pharmacological activities of B. serrata. The resin fraction 
of Salai guggal is rich in boswellic acids and its essential oils that are composed of a mixture of mono-, di-, and sesqui-terpenes while gum fraction 
chiefly contains pentose and hexose sugars. The oleo-gum resin is highly sought after by the practitioners of traditional system because it has shown 
broad range of efficacy in asthma, cancer, microbial/fungal infections, hyperlipidemia, inflammation, arthritis, diarrhea, and management of pain. An 
exhaustive review of literature was conducted using various databases on ScienceDirect, Scopus, PubMed, Google Scholar, and Free Patents online. 
This review is a sincere attempt to discuss and present the current status of pharmacological profile of B. serrata.
Keywords: Boswellia serrata, Inflammation, Boswellic acids, Leukotriene synthesis, Pharmacology.
INTRODUCTION
Boswellia serrata (Fig. 1) (Kundur) is commonly known as “Salai guggal” 
owned by the family Burseraceae. The tree is commonly found in Southern 
Arabia, West Asia, Oman, South Africa, and Yemen. In India, it is widely 
distributed in Western Himalayas, Madhya Pradesh, Gujarat, Orissa, 
Rajasthan, Bihar, and Maharashtra. It is a moderate to large deciduous 
tree with a circumference of 2.4 m and medium height of 4–5 m. The 
papery bark changes its color from greenish-gray, yellow, or reddish to 
ash color which can be easily peeled off. On peeling or incision, the barks 
secrete an exudate in the form of translucent lumps, tears, or droplets of 
white to yellow-colored gummy oleo-gum resin. The aromatic gum has 
balsamic odor and bitter taste. In Ayurveda, an Indian traditional system 
of medicine, the gum is used for the treatment of number of inflammatory 
diseases affecting skin, eye, gums, and gastrointestinal tract in addition to 
the respiratory disorders such as asthma, bronchitis, and laryngitis [1].
Salai guggal or oleo-gum resin is a mixture of gum, resin, and essential 
oil. Hexose and pentose sugars with certain digestive and oxidizing 
enzymes make up the gum. Combination of some phenolics, mono-, di-, 
and sesqui-terpenes and a diterpene alcohol is found in the essential oil 
fraction. The resin part of almost all species of Boswellia is mainly made 
up of boswellic acid (BA), a pentacyclic triterpene acid [2,3].
A number of reviews and research papers focusing on pharmacological 
studies have highlighted the usefulness of BAs in the management of 
several chronic inflammatory diseases including chronic ulcerative 
colitis, rheumatoid arthritis, Crohn’s disease, and bronchial asthma; in 
addition to its antidepressive, antianxiety, and beneficial effects in brain 
tumor patient [4].
The two most efficient anti-inflammatory BAs of Boswellia are 11-keto-beta-
BA (KBA) and acetyl-KBA (AKBA) [5]. BAs selectively inhibit leukotriene 
formation by inhibiting 5-lipoxygenase (5-LOX) in a non-competitive, 
non-redox, and enzyme-directed manner. They also exhibit various effects 
such as antioxidant, cancer drug sensitizing, antinociceptive, antibacterial, 
insulin resistance lowering, and cardioprotective.
Pharmacognostical characteristics of Indian Boswellia
Macroscopically, the oleo-gum resin occurs as transparent, brownish-
yellow, 2 cm thick, stalactic tears that constitute agglomerates of different 
sizes and shape, fracture, fragrant, brittle; ruptured waxy surface and 
translucent; and burn voluntarily and emanate an appealing characteristic, 
balsamic resinous odor and taste is pungent, bitterish, and slightly 
aromatic but agreeable. Microscopically, debris of fibers, rectangular cork, 
yellowish oil globules, and innumerable large or small, oval to round or 
rhomboidal crystalline fragments are present [6]. In general, exudate, 
bark, trunk, and oleo-gum resin of B. serrata are used medically [7].
In India, it is one of the most common trees found in some parts of 
Khandesh, Loonawara, and other neighboring territories [8]. It is a native 
of the mountainous parts of Coromandel, attaining a large size [9]. It is also 
spotted in dry hilly forest regions of Madhya Pradesh, Rajasthan, Bihar, 
Orissa, Assam, as well as peninsular central regions of Andhra Pradesh [10]. 
Table 1 gives the botanical description of the plant [11,12].
Phytochemistry
Various important phytochemicals are found in oleo-gum resin 
mixture. These include mucus, pure resin, and essential oil. The 
content and composition of oleo-gum resin may vary from species to 
species depending on resin’s quality, age, and geographical conditions. 
The resins of Boswellia species chiefly contain higher terpenoids, 
i.e., pentacyclic triterpenes and tetracyclic triterpenes and are 
responsible for its pharmacological effects [13,14].
The six major BAs are α- and β-BAs (10–21%), KBA (2.5–7.5%), 
acetylated α- and β-BAs (0.05–6%), and 3-o-AKBA (0.1–3%). The 
content of BAs in commercially available standardized extract varies 
from 37.5 to 65% [13].
The dry extract of B. serrata contains approximately 50–60% of 
various α- and β-BAs, of which 1–3% is the most bioactive AKBA 
fraction [15,16]. Among all the BAs of Boswellia, the two most active, 
potent, and anti-inflammatory agents are AKBA and KBA. The lipophilic 
part of AKBA with a β-configuration has been described to have 
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superior anti-inflammatory properties over α-configuration [17]. Some 
other BAs isolated from Boswellia are 9, 11-dehydro-α-BAs and its 
isomer and their acetylated group form. The other phytoconstituents 
found in Boswellia are incensole acetate, acetyl-lupeolic acid, lupeolic 
acid, incensole oxide, and isoincensole oxide [18-24].
Modification in chemistry of BAs alters their biological effect. When 
11-keto group of BA is modified to methylene group, 5-LO activity has 
been observed to decrease. However, reduced form is more efficient 
toward induction of apoptosis and inhibition of topoisomerases. 
Removal of acetyl group or reduction of 11-keto group to alcohol in 
AKBA produces slight decrease in activity of 5-LO inhibition suggesting 
that the 11-keto functionality and pentacyclic triterpene ring are critical 
for receptor attachment to produce anti-inflammatory activity [25].
The essential oil of Salai guggul mainly contains monoterpenes 
such as α-pinene (major monoterpene), trans-pinocarveol, myrcene 
cis-verbenol, borneol, limonene, phellandrene, cadinene, verbenone, 
thuja 2, 4(10)-diene, p-cymene, and small amount of diterpenes [26].
Chemistry of various BAs
Structures of various pentacyclic triterpenic acids (BAs) are illustrated 
in Fig. 2.
Pharmacokinetics properties of BA
AKBA and KBA are lipotropic fractions of BA responsible for their poor 
intestinal penetration and high retention [28,29]. Literature reports 
that the bioavailable plasma levels of various BAs were enhanced many 
folds by simultaneous administration of a fat-rich food [16].
Various studies to improve bioavailability of BA have been reported 
in literature. Recently, Bairwa and Jachak (2016) developed a 
polydilactide coglycoside-based nanotechnique for KBA to enhance its 
oral bioavailability and in vivo anti-inflammatory activity [30]. Hüsch 
et  al. (2013) formulated B. serrata gum resin extract into Casperome, 
a soy lecithin formulation which showed significantly high level of KBA 
and β-BA fraction [31].
Sengupta et al. (2011) characterized a novel formulation called Aflapin, 
which consists of B. serrata extract (BSE) rich in AKBA and non-volatile 
oil part of B. serrata resin. In Aflapin-supplemented animals, the level 
of AKBA is increased by 51.78% in systemic circulation in comparison 
with 30% standardized AKBA extract. Aflapin showed better anti-
inflammatory efficacy in Freund’s complete adjuvant-induced 
inflammation model in Sprague-Dawley rats [32].
Fartyal et al. (2011) studied floating microspheres using BA for 
prolongation of gastric retention time [33]. Sharma et al. (2010) studied 
the complexation of BA with phosphatidylcholine (PC) to enhance 
its bioavailability [34]. The compound showed better hypolipidemic 
activity and anti-inflammatory activity as compared to BA. The obtained 
result revealed that increased bioavailability of BA-PC complex may be 
due to amphiphilic nature of the complex, which, in turn, enhanced the 
lipid and water solubility of BAs.
Goel et al. (2010) developed AKBA-loaded polymeric nanomicelles 
which showed magnified antiarthritic, anti-inflammatory, and skin 
permeability activities [35].
Mechanism of action
The most promising targets for BAs are 5-LO, angiogenesis, 
topoisomerases, and cytochrome p450 enzyme (Fig. 3) [17,36-38].
5-LO inhibition
In neutrophils, 5-LO predominantly converts endogenous arachidonic 
acid to leukotrienes and 5-hydroxyeicosatetraenoic acid. They 
cause vasoconstriction, bronchospasm increased permeability 
and chemotaxis. BA is a unique, specific, non-redox inhibitor of 
5-LO as it neither impairs the cyclooxygenase and 12-lipoxygenase 
enzyme properties nor inhibits the peroxidation of arachidonic 
acid [17,31,34,36-46].
Topoisomerase inhibition
BAs have a real catalytic inhibitory action on human topoisomerase. 
BAs not only inhibit DNA formation in human leukemic promyelocytic 
cells in a dose-dependent manner but also inhibit topoisomerase 
through binding with the enzyme [17,41-44].
Leukocyte elastase inhibition
The human elastase decreases the elasticity of lungs, constricts 
the lungs passages, damages the secretion of mucus in lungs, and 
decreases the removal of the mucus. In addition to this, it disrupts 
skin cells and causes swelling, redness, and edema that are symptoms 
of inflammation. BAs reduce the activity of elastase enzyme which is 
responsible of emphysema. AKBA and KBA have been expressed to 
retard elastase in a dose-dependent way [44].
Inhibition of C2 and C3 convertase
BAs inhibit the C2 convertase enzyme which has the most significant 
role in the classical complement pathway for specific immunity [45]. 
BAs have been observed to inhibit hemolysis and chemotaxis of 
leukocytes and inhibit a crucial enzyme C-3 convertase of the 
classical complementary pathway [45,47,48]. Safayhi and Sailer 
reported that AKBA and KBA were the strong 5-LO inhibitors with 
half maximal inhibitory concentration values of 1.5 µM and 3.0 µM, 
respectively [37,49].
Effect of BA on various organs
BAs are characterized by their ability to act on multiple targets which 
are compiled in Table 2.
Fig. 1: Boswellia serrata
Table 1: Botanical genesis and native names of Boswellia serrata
Botanical origin Native names
Species: Serrata English – Indian frankincense
Genus – Boswellia Hindi – Salai, Kundur
Family – Burseraceae Gujarati – Gugali, Dhup
Class – Anacardiales Malayalam – Saambraani, Parangi
Over-class – Rutanae Telugu – Saambraani, Phirangi
Subtribe – Rosidae S. lat. Sanskrit – Kunduru, Ashvamurti, 
Shallaki
Tribe – Rosopsida Tamil – Saambraani, Parangi
Sub- division- Angiospermae Kannada- Guguladhuph, Chitta
Division- Spermatophyte Bengali- Salai, Kundur
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Pharmacological profile of BAs
Antiarthritic and anti-inflammatory activity
Carrageenan and dextran are widely utilized to induce paw edema for 
screening of anti-inflammatory action of drugs. Singh and Atal observed 
that oral administration of an alcoholic extract of the oleo-gum resin of BS 
caused inhibition of the carrageenan-induced edema in rats and mice and 
dextran-induced edema in rats. Numerous scientific studies clearly support 
the privilege that BS possesses potent anti-inflammatory activity [50].
The anti-inflammatory activity of BAs is due to inhibition of leukotriene 
synthesis through 5-LO; however, they have no effect on cyclooxygenase, 
12-lipoxygenase arachidonic acid peroxidation by ascorbate, and iron. 
The data demonstrated that BAs from B. serrata are specific, non-redox 
inhibitors of leukotriene synthesis either by interacting immediately 
with 5-LO or restricting its translocation and thus act as a potent anti-
inflammatory agent [17]. The inhibition of 5-LO by BAs that lead to 
decreased production of leukotrienes has received high attention by 
scientific society since a variety of chronic inflammatory diseases are 
connected with increased leukotrienes activity [51].
Extract of B. serrata leads to inhibition of carrageenan-induced paw 
edema by 39.75% and 65–73% with a dose of 50–200 mg/kg (p.o) 
and 50–100 mg/kg (i.p) appropriately compared to 47% inhibition 
seen with phenylbutazone (50 mg/kg p.o.). The anti-inflammatory 
activity was equally well noted in adrenalectomized rats. Inhibition of 
paw swelling (34% and 49%) has been seen with the mycobacterial 
adjuvant-induced polyarthritis in rats [50].
Ammon et al. (1991) implemented studies on leukocytes migration into 
the inflammatory exudates induced by carrageenan. Extract of B. serrata 
Fig. 2: Structures of various boswellic acids (pentacyclic acids) present in frankincense [27]
Table 2: Beneficial uses of Salai guggul in the standard Indian 
Ayurvedic system [1]
Organ and functional system Effects
Cardiovascular system Cardiotonic
Gastrointestinal tract Carminative
Regulating color of stool
Anthelmintic
Improving digestion
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in dose of 100 mg/kg orally showed significant diminishing effect on 
both the leukocytes population and volume of pleural exudates [36]. 
Singh and Atal (1984) calculated the anti-inflammatory effect of 
mixture of BAs, and in formaldehyde arthritis model, it exhibited 
45–67% antiarthritic activity. It has been shown to be effective in 
adjuvant arthritis (35–59%) as well as in established arthritis 
(54–84%), also relieved fever [50]. Kulkarni et al. and Chopra et al. have 
conducted clinical trials for establishing anti-inflammatory properties 
of Boswellia, in combination with Curcuma longa, Zingiber officinale, 
and Withania somnifera. Treatment with this combination produced 
significant decrease in disability score and severity of pain [52,53].
Sharma et al., in 1989, studied the effectiveness of BA on bovine 
serum albumin (BSA)-induced arthritis model in rabbits. The oral 
administration of BA (25, 50, and 100 mg/kg/day) remarkably lessened 
the leukocytes in BSA-injected knee which changed the electrophoretic 
pattern of the synovial fluid protein [51]. Gupta et al. (1992) found 
BAs to be much more effective in the latex of papaya-induced model 
of inflammation than carrageenan-induced inflammation. In the 
carrageenan model, the effect of acetylsalicylic acid was compared 
with the action of prednisolone and BAs. This suggests that the anti-
inflammatory activity of BAs is different from aspirin-like drugs and 
prednisolone. BAs did not inhibit prostaglandin synthesis but were 
more effective in inhibition of leukotriene synthesis [54].
It has been also reported that BAs produce the anti-inflammatory actions 
in mouse macrophages and human peripheral blood mononuclear cells 
through inhibition of mitogen-activated protein kinases (MAPK), NO, 
tumor necrosis factor-alpha (TNF-α), and interleukin-1β [55].
Khosravi et al., in 2011, organized a double-blind randomized clinical 
trial to assess the effectiveness of Boswellia in moderate plaque-
induced gingivitis. They reported that the Boswellia extract had the 
ability to lessen the inflammation of periodontium associated with 
plaque-induced gingivitis [56].
Notarnicola et al. assessed the effectiveness of the combination of BA-
methylsulfonylmethane (MSM) in comparison to glucosamine (GS) as 
an effective supplement in the management of knee arthritis through 
a clinical trial. It was found that the BS-MSM combination showed 
promising and satisfactory results with respect to GS [57].
Review articles published in the past for preclinical and clinical studies 
have clearly highlighted and supported the anti-inflammatory activities 
of B. serrata.
Analgesic effect
B. serrata is used to treat muscular and arthritic pain in various systems 
of medicine [58-60]. Menon and Kar exhibited that the non-phenolic 
fraction of B. serrata possesses remarkable analgesic and sedative effect. 
They also revealed significant reduction in the spontaneous locomotor 
activity after treatment with Boswellia [61]. Sharma et al. investigated the 
analgesic activity of various fractions of B. serrata distinctly by formalin 
test, acetic acid-induced writhing, hot plate methods, and tail immersion 
model of analgesic in rats [60]. Both peripherally and centrally mediated 
analgesic action were measured. Tail immersion methods and acetic acid-
induced abdominal constriction elucidated central and peripheral activity, 
respectively, although the formalin test measured both. Peripheral effects 
were elucidated by hot plate method [62]. They not only assessed the 
analgesic activity but also elucidated the mode of action. The oleo-gum 
resin fraction showed maximal inhibition (60.54%) as compared to 
gum (54.88%) and oil (20.70%) fraction. In 2005, Bishnoi et al. examined 
the analgesic activity of AKBA at different dose levels by tail flick and 
acetic acid-induced writhing method in mice. In acetic acid-induced 
writhing method, a dose-dependent increase in antinociceptive activity 
of AKBA was shown while in tail flick method, 100 mg of AKBA showed 
similar response to 200 mg. AKBA was found to be significantly better 
than positive control, nimesulide [63]. Al-Harrasi et al. used formalin-
induced pain and acetic acid-induced writhing to investigate the analgesic 
activity of Boswellia sacra in mice. Polar subfraction was observed with 
highest analgesic activity, almost double of positive control, aspirin. The 
study proposed that Boswellia seems to produce antinociceptive effect by 
both peripheral and central mechanism [64].
Antifungal activity
In a study using agar well diffusion method, Chaurasia and Gharia 
investigated the antifungal activity of B. serrata against plant pathogenic 
Fig. 3: Mechanism of action of boswellic acids
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fungus (red rot disease-causing agent) Colletotrichum falcatum. They 
extracted the plant with water, ethanol, and chloroform and concluded 
that the ethanolic extract of plant was much more efficient than 
chloroform extract [65].
Garg (1974) studied antifungal activity of B. serrata and found that on 
hydrodistillation B. serrata produced 0.6% of essential oil. The oil has 
mild antifungal activity against human pathogens and highly effective 
against plant pathogens, seen by inhibition of the tested organisms, 
namely Phytophthora parasitica [66].
Antihyperlipidemic and antidiabetic activity
Olibanum gum resin has traditionally been used in the treatment of 
diabetes in patients and has been recognized with its beneficial effects 
in a large number of diseases. Several investigations in rat’s model 
showed that BSE of olibanum gum resin significantly decreased total 
cholesterol and has potential hypolipidemic and hepatoprotective 
activities [67,68]. A study has also been carried out for comparison 
between olibanum resin and placebo for the curing of type 2 diabetes 
in double-blinded clinical trial on 71 patients. They suggested that 
olibanum gum resin improves glycemic control and lowers the blood 
levels of glucose, HbA1c, insulin, total cholesterol, and triglycerides [69].
An herbal formulation of B. serrata gum resin has been documented 
to induce powerful hypoglycemic effect by affecting hepatic 
gluconeogenesis and phosphoenolpyruvate carboxykinase [70]. At 
different dose levels (25–50 mg/kg. p.o.), the alcoholic extract exhibited 
antihyperlipidemic activity with hypercholesterolemic animals and 
lowered cholesterol (30–50%) and triglycerides (20–60%) levels [71]. 
The past studies and research clearly revealed that Boswellia is 
an effective antihyperlipidemic agent. Hydrophilic portion of BSE 
enhanced high-density lipoprotein and diminished the concentration 
of total cholesterol (38–48%) in experimental animals. Zutshi et al. 
observed that Salai guggal retains optimum levels of serum cholesterol 
and triglycerides in animals, which were fed high cholesterol and 
saturated fat-rich diet [72]. AKBA has been exhibited to inhibit the 
activity of nuclear factor kappa B (NF-kB) in atherosclerosis. Liu et al. 
found that AKBA is known to have anti-adipocyte property by virtue of 
which it induces lipolysis in mature human adipocytes [73].
Antimicrobial and antioxidant effects
Ismail et al. reported that the resin extract of Salai guggal powder 
demonstrated microbicidal activity in different concentration ranges 
(25, 50, 75, and 100 mg/ml) against of Gram-negative (Proteus vulgaris, 
Klebsiella pneumonia, Pseudomonas aeruginosa, Escherichia Coli, and 
Enterobacter aerogenes) and Gram-positive (Staphylococcus aureus, 
Bacillus subtilis, and Streptococcus pneumonia) microbes. They observed 
the inhibition zone and compared with antibiotic ciprofloxacin 
(5 µg/ml) as positive control and dimethyl sulfoxide as a negative 
control [74].
Patel and Patel evaluated the antibacterial activity of extracts of 
B. serrata in acetone, water, methanol, and petroleum ether on Gram-
negative urinary tract infection pathogens (K. pneumonia, E. coli, 
P. vulgaris, and P. aeruginosa) by disk diffusion method. The acetone 
extract was found to have significant antibacterial activity against 
K. pneumonia and E. coli with minimum inhibitory concentration 
value of 12.5 µg/µl [75]. Baratta et al., 1998, studied antimicrobial 
and antioxidant activity and determined the essential oil of B. serrata 
by gas chromatography (GC) and GC–mass spectrometry. The volatile 
oil portion possessed significant antimicrobial activity against all 
the test organisms and comparable antioxidant activity to butylated 
hydroxytoluene and α-tocopherol [76].
Raja et al. tested the antibacterial activity of BAs against a variety of 
pathogenic Gram-negative and Gram-positive bacteria and concluded 
that AKBA was the most potent constituent with antibacterial potential 
among all BAs but only against Gram-positive bacteria [77].
Antiasthmatic activity
The resins of B. serrata have been described to inhibit leukotriene 
biosynthesis and have a beneficial effect on respiratory disorders. It is 
used in massages, bath and treatment of cough, excessive discharge or 
buildup of mucus in the nose or throat, asthma, and bronchitis.
It was confirmed by Gupta et al. (1998) that alcoholic extract of B. serrata 
has remarkable effect in asthma. In a double-blind placebo control 
clinical study, they studied promising antiasthmatic effect of alcoholic 
extract of Salai guggal with 70% of the patients showing recovery in 
physical symptoms and signs of bronchitis and dyspnea. Mobilization 
of intracellular Ca2+ and induction of MAPK were also observed [78,79].
Liu et al. investigated the antiasthmatic potential and studied the 
action of BA in murine model of asthma. They found that the animals 
treated with the BA could suppress the allergic inflammation, 
hyperresponsiveness, Th2 cytokines secretion, and ovalbumin-specific 
IgE [80]. BA was reported to reduce the infiltration of cells, lessen 
the demolition of lung structure, and attenuate fibrotic lungs by 5-LO 
inhibition action in an experimental model of pulmonary fibrosis using 
bleomycin [81].
Antidiarrheal activity
BAs from B. serrata were effective in controlling diarrhea without 
causing constipation in patients with inflammatory bowel syndrome. 
They also inhibited contraction of intestinal smooth muscles, thereby 
controlling acetylcholine and barium chloride-induced diarrhea [82].
Anticancer activity
BSE has been shown to halt the brain tumor and breast cancer metastases. 
BSE comprised 60% BAs have apparently repressed inflammation and 
tumor in mice. Antineoplastic effect has been investigated in mice with 
Ehrlich ascites carcinoma and S-180 tumor by interfering with the 
biosynthesis of DNA, RNA, and protein which caused inhibition in cell 
proliferation. The potency of BSE against the peritumoral edema can be 
magnified by enhancing the bioavailability of AKBA [2].
B. serrata showed antitumor effect in diverse types of tumor cells 
including prostate, colon, leukocytes, brain, and liver. AKBA was found 
with an inhibitory effect on NF-kB and also potentiated apoptosis and 
inhibition of angiogenesis in neoplastic cells by signaling transducer 
pathway and activation of transcription 3-related pathways [43,83-88].
In addition to this, Sinha et al. showed in vivo Matrigel plug assay that 
BAs inhibit basic fibroblast growth factor-induced angiogenesis [89].
Ahmed et al. studied the potency of B. serrata methylene chloride extract 
against colon cancer induced in animals and also evaluated the serum 
epidermal growth factor, matrix metalloproteinase (MMP)-9, MMP-7, 
plasma transforming growth factor-β (TGF-β), and TNF-α levels using 
ELISA. Cyclin D1 and colon cyclooxygenase-2 (COX-2) expressions were 
estimated by immunohistochemical technique. Colon cancer group was 
found with sufficient elevation in cyclin D1 and COX-2 expressions in 
colon cells, whereas all treatment groups showed marked decrease in 
cyclin D1 and COX-2 expression. This study reflected the therapeutic 
role of B. serrata against colon carcinoma developed in rats [90].
Pang et al. prepared BA nanoparticle formulation for the treatment of 
prostate cancer. BA nanoparticles caused DNA fragmentation, which is 
a hallmark of apoptosis [85].
McCarty reported BAs as cancer chemopreventive agents and was found 
to lessen tumor cell invasiveness and tumor cell motility, to moderate 
tumor development, and to reduce tumor angiogenesis [91].
Anticomplementary activity
In a study of antibody-coated sheep erythrocytes by pooled guinea pig 
serum, BAs have been found to inhibit immunohemolysis. Retardation 
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of the C3-convertase enzyme with a threshold concentration of 
100 µg of the classical complement pathway caused decreased in 
immunohemolysis. BA has also showed hindering effect on guinea pig 
serum by in vivo technique [92].
BAs were also found to inhibit hemolysis and chemotaxis of 
leukocytes and were shown to work by inhibiting the key enzyme of 
the classical complementary pathway, namely C3-convertase, a serine 
protease [45,47,48] and were found to possess anticomplementary 
activity.
Clastogenic activity
The consumption of Boswellia serrata is believed to improve memory, 
learning, performance, and cognitive behavior. It is also recommended 
for pregnant women to raise the intelligence and memory of their 
offsprings [93]. Aqueous extract of B. serrata, W. somnifera, and 
Spirulina alga produced clastogenic effect and was found to be effective 
in stress relief and memory boost. All these results were recognized 
to be dose dependent and may be due to the binding of BAs with 
neurotransmitter signaling pathways or protein kinase pathways in 
brain [94].
Antidepressant activity
B. serrata has been reported to be efficient in acute model of depression. 
Prabhakar et al. showed that at a dose of 100 mg/kg, B. serrata has 
notable antidepressant activity in acute models of depression and 
that they lessen the immobility period in forced swim experimental 
model [95].
Branded formulations containing B. serrata [1]
Apart from its use in spiritual ceremonies, Boswellia has been practiced 
as an important adhesive in lotions, creams, perfumes, and detergents, 
with an oriental note in its scent, in prominent products of the perfume 
and cosmetic industry. Many preparations with B. serrata are assessable 
in the markets which are elaborated below:
• Boswellin®, a certified trademark by Sabinsa Corporation was 
popularized in the US and European markets in 1991. It is available 
in tablet or capsule forms and also in a calming pain diminishing 
cream consisting capsaicin. Product comprises BAs ranging from 
150 to 250 mg/capsule or tablet, to be taken orally twice to thrice a 
day.
• Niltan® is a cream formulation for external use, produced by 
Dr. Reddy’s Laboratories Limited, Hyderabad. It is a unification of 
active herbal extracts (arbutin, boswellin, coriander seed oil, and 
liquorice extract in a semisolid base). It imparts its action by reducing 
the enzyme tyrosinase in the skin, also diminishing the level of 
melanin, which is responsible for darkness of skin.
• Shallaki®, each capsule consists of 125 mg B. serrata. It has certified 
anti-inflammatory and analgesic effects advantageous in relieving 
joint pains, produced by Himalayan Company, Makali, Bengaluru.
• Rheumatic-X® consists of 20 mg “Shallaki” along with a number of 
ingredients, produced by Sunrise Herbals, Banaras (U.P., India), and 
prescribed for osteoarthritis, gout, rheumatoid, and pain.
CONCLUSION
The present review focuses on the scientific recognition of the 
remedial usefulness and action of B. serrata once used in cultural 
and religious ceremonies but now valued for its numerous beneficial 
medicinal effects. BAs are the bioactive phytoconstituents which 
have demonstrated promising results in numerous experiments 
and clinical studies. Their medicinal properties are also widely 
recognized for the treatment of ailments ranging from inflammatory 
conditions, microbial infections to cancer. In addition to this, its 
products have been recommended for topical use in the treatment of 
chronic and excessively damaged skin. Future challenges are toward 
understanding the drug-drug interactions, molecular mechanism, 
and development of strategies to improve their pharmacokinetic 
profile.
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